» Articles » PMID: 22561871

Plasma MicroRNAs Are Sensitive Indicators of Inter-strain Differences in the Severity of Liver Injury Induced in Mice by a Choline- and Folate-deficient Diet

Overview
Specialties Pharmacology
Toxicology
Date 2012 May 8
PMID 22561871
Citations 50
Authors
Affiliations
Soon will be listed here.
Abstract

MicroRNAs (miRNAs) are a class of small, conserved, tissue-specific regulatory non-coding RNAs that modulate a variety of biological processes and play a fundamental role in the pathogenesis of major human diseases, including nonalcoholic fatty liver disease (NAFLD). However, the association between inter-individual differences in susceptibility to NAFLD and altered miRNA expression is largely unknown. In view of this, the goals of the present study were (i) to determine whether or not individual differences in the extent of NAFLD-induced liver injury are associated with altered miRNA expression, and (ii) assess if circulating blood miRNAs may be used as potential biomarkers for the noninvasive evaluation of the severity of NAFLD. A panel of seven genetically diverse strains of inbred male mice (A/J, C57BL/6J, C3H/HeJ, 129S/SvImJ, CAST/EiJ, PWK/PhJ, and WSB/EiJ) were fed a choline- and folate-deficient (CFD) diet for 12weeks. This diet induced liver injury in all mouse strains; however, the extent of NAFLD-associated pathomorphological changes in the livers was strain-specific, with A/J, C57BL/6J, and C3H/HeJ mice being the least sensitive and WSB/EiJ mice being the most sensitive. The morphological changes in the livers were accompanied by differences in the levels of hepatic and plasma miRNAs. The levels of circulating miR-34a, miR-122, miR-181a, miR-192, and miR-200b miRNAs were significantly correlated with a severity of NAFLD-specific liver pathomorphological features, with the strongest correlation occurring with miR-34a. These observations suggest that the plasma levels of miRNAs may be used as biomarkers for noninvasive monitoring the extent of NAFLD-associated liver injury and susceptibility to NAFLD.

Citing Articles

Novel Multi-Ingredient Supplement Facilitates Weight Loss and Improves Body Composition in Overweight and Obese Individuals: A Randomized, Double-Blind, Placebo-Controlled Clinical Trial.

Nederveen J, Mastrolonardo A, Xhuti D, Di Carlo A, Manta K, Fuda M Nutrients. 2023; 15(17).

PMID: 37686725 PMC: 10490028. DOI: 10.3390/nu15173693.


Role of extracellular vesicles in nonalcoholic fatty liver disease.

Jiang W, Xu Y, Chen J, Lee Y, Hu Y, Liu C Front Endocrinol (Lausanne). 2023; 14:1196831.

PMID: 37534206 PMC: 10392952. DOI: 10.3389/fendo.2023.1196831.


Significance of MiRNA-34a and MiRNA-192 as a risk factor for nonalcoholic fatty liver disease.

Ragab H, Ezzat W, Mahmoud Hassan E, Maksoud N, Afify M, Abd El-Maksoud M J Genet Eng Biotechnol. 2023; 21(1):13.

PMID: 36757530 PMC: 9911573. DOI: 10.1186/s43141-023-00467-z.


Exosomal microRNAs and Progression of Nonalcoholic Steatohepatitis (NASH).

Qi X, Lai J Int J Mol Sci. 2022; 23(21).

PMID: 36362287 PMC: 9654542. DOI: 10.3390/ijms232113501.


Pro-Neurotensin as a Potential Novel Diagnostic Biomarker for Detection of Nonalcoholic Fatty Liver Disease.

Mohamed A, Abo-Elmatty D, Ezzat O, Mesbah N, Ali N, Abd El Fatah A Diabetes Metab Syndr Obes. 2022; 15:1935-1943.

PMID: 35769889 PMC: 9234179. DOI: 10.2147/DMSO.S365147.


References
1.
Tiniakos D, Vos M, Brunt E . Nonalcoholic fatty liver disease: pathology and pathogenesis. Annu Rev Pathol. 2010; 5:145-71. DOI: 10.1146/annurev-pathol-121808-102132. View

2.
Chalasani N, Guo X, Loomba R, Goodarzi M, Haritunians T, Kwon S . Genome-wide association study identifies variants associated with histologic features of nonalcoholic Fatty liver disease. Gastroenterology. 2010; 139(5):1567-76, 1576.e1-6. PMC: 2967576. DOI: 10.1053/j.gastro.2010.07.057. View

3.
Pogribny I, Starlard-Davenport A, Tryndyak V, Han T, Ross S, Rusyn I . Difference in expression of hepatic microRNAs miR-29c, miR-34a, miR-155, and miR-200b is associated with strain-specific susceptibility to dietary nonalcoholic steatohepatitis in mice. Lab Invest. 2010; 90(10):1437-46. PMC: 4281935. DOI: 10.1038/labinvest.2010.113. View

4.
Yang H, Wang J, Didion J, Buus R, Bell T, Welsh C . Subspecific origin and haplotype diversity in the laboratory mouse. Nat Genet. 2011; 43(7):648-55. PMC: 3125408. DOI: 10.1038/ng.847. View

5.
Wang B, Majumder S, Nuovo G, Kutay H, Volinia S, Patel T . Role of microRNA-155 at early stages of hepatocarcinogenesis induced by choline-deficient and amino acid-defined diet in C57BL/6 mice. Hepatology. 2009; 50(4):1152-61. PMC: 2757532. DOI: 10.1002/hep.23100. View